The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.

[1]  A. Mahajan,et al.  Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma. , 2017, Human pathology.

[2]  H. Gabra,et al.  Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium. , 2017, European journal of cancer.

[3]  Lei Zhou,et al.  Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma , 2017, Diagnostic Pathology.

[4]  Weilong Chang,et al.  Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis , 2015, PloS one.

[5]  Yong-He Hu,et al.  ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis. , 2015, Heart, lung & circulation.

[6]  J. Nesland,et al.  The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study , 2015, BMC Cancer.

[7]  Xiaohua Wu,et al.  High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients , 2015, Gynecologic and Obstetric Investigation.

[8]  Zhuling Yang,et al.  Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression , 2015, Pathology & Oncology Research.

[9]  G. Kristiansen,et al.  Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer , 2015, Oncotarget.

[10]  E. Morii,et al.  Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. , 2015, Gynecologic oncology.

[11]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[12]  I. Shih,et al.  Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma , 2015, Modern Pathology.

[13]  R. Rouzier,et al.  Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma. , 2015, Gynecologic oncology.

[14]  Chengyong Zhou,et al.  The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. , 2014, Oral oncology.

[15]  C. Landen,et al.  Ovarian cancer stem cells: are they real and why are they important? , 2014, Gynecologic oncology.

[16]  Y. Li,et al.  Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas , 2014, Cellular Physiology and Biochemistry.

[17]  You-hong Cui,et al.  ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis , 2014, BMC Cancer.

[18]  Zhihong Zhang,et al.  Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma. , 2013, Human pathology.

[19]  J. Akiba,et al.  Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line , 2013, PloS one.

[20]  Michael J. Parsons,et al.  Aldh1-Expressing Endocrine Progenitor Cells Regulate Secondary Islet Formation in Larval Zebrafish Pancreas , 2013, PloS one.

[21]  R. Buckanovich,et al.  Ovarian cancer stem cells: working towards the root of stemness. , 2013, Cancer letters.

[22]  C. Denkert,et al.  Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma. , 2013, Human pathology.

[23]  Tsuyoshi Saito,et al.  ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis , 2013, PloS one.

[24]  G. Enikolopov,et al.  Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche , 2013, Nature.

[25]  R. Berkowitz,et al.  Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures , 2012, BMC Cancer.

[26]  Sean J Morrison,et al.  Cancer stem cells: impact, heterogeneity, and uncertainty. , 2012, Cancer cell.

[27]  Yu‐Chi Wang,et al.  Tumorigenesis and Neoplastic Progression ALDH 1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD 44 Expression , Drug Resistance , and Poor Clinical Outcome , 2012 .

[28]  Yuzhi Shi,et al.  Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma , 2012, Medical Oncology.

[29]  Kenneth P. Nephew,et al.  Rethinking ovarian cancer: recommendations for improving outcomes , 2011, Nature Reviews Cancer.

[30]  R. Ozols,et al.  The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. , 2011, Gynecologic oncology.

[31]  K. Griffith,et al.  Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. , 2011, Cancer research.

[32]  E. Morii,et al.  Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications , 2011, Cancer science.

[33]  Toshio Mori,et al.  Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. , 2010, Oncology reports.

[34]  Lin Zhang,et al.  Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers , 2010, PloS one.

[35]  Tao Zhang,et al.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.

[36]  D. Rosen,et al.  ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers , 2009, Modern Pathology.

[37]  H. Baker,et al.  ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells , 2008, Molecular Cancer.

[38]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[39]  Hys Ngan,et al.  Carcinoma of the Ovary , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[40]  P Maisonneuve,et al.  Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[41]  F. Gonzalez-fernandez,et al.  Cancer stem cell characteristics in retinoblastoma. , 2005, Molecular vision.

[42]  S. Bapat,et al.  Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. , 2005, Cancer research.

[43]  E. Trimble,et al.  Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis , 2002 .

[44]  T. Dragani,et al.  Downexpression of aldehyde dehydrogenase 1 in murine lung tumors , 1996, Molecular carcinogenesis.

[45]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.